The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...

SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech ...

Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

The way the world grows protein is straining the planet. Raising animals for food covers close to 40 percent of all farmland, and it releases nearly 14.

Postharvest losses in fruits, particularly apples, are a significant global issue. New research sheds light on how the immune ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

Sarepta Therapeutics (NASDAQ:SRPT) is at the forefront of gene therapy innovations, often highlighted in today’s market ...

An update from Targovax ASA ( ($GB:0RIS) ) is now available. Circio Holding ASA has announced a proposed rights issue to raise up to NOK 50 ...